Singapore - English - HSA (Health Sciences Authority)

covidien private limited - general hospital - the invos™ patient monitor, model pm7100, is a noninvasive cerebral/somatic oximetry system intended for use as an adjunct monitor of regional hemoglobin oxygen saturation of blood in the brain or in other tissue beneath the sensor. it is intended for use on individuals >2.5 kg at risk for reduced-flow or no-flow ischemic states. for patients ≤2.5 kg, the invos™ patient monitor, model pm7100 is only intended for adjunct trend monitoring of regional hemoglobin oxygen saturation of blood tissue beneath the sensor. it is also intended for use as an adjunct trend monitor of regional hemoglobin oxygen saturation of blood tissue beneath the sensor in any individual.

Singapore - English - HSA (Health Sciences Authority)

covidien private limited - general hospital - the noninvasive invos™ carescape™* rso2 – invos™ parameter device when connected to the compatible host monitoring system is intended for use as an adjunct monitor of regional hemoglobin oxygen saturation of blood in the brain or in other tissue beneath the sensor. it is intended for use on individuals greater than 40 kg (88 lbs) at risk for reduced-flow or no-flow ischemic states.

Singapore - English - HSA (Health Sciences Authority)

covidien private limited - general & plastic surgery - is intended for use as an adjunct monitor of regional hemoglobin oxygen saturation of blood in the brain or in other tissue beneath the sensor. it is intended for use in individuals greater than 2.5 kg at risk for reduced-flow or no-flow ischemic states. it is also intended for use as an adjunct trend monitor of regional hemoglobin oxygen saturation of blood in the brain or in other tissue beneath the sensor in any individual.

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - 17942 - oximeter, cerebral - the noninvasive invostm carescapetm* rso2 ? invostm parameter device when connected to the compatible host monitoring system is intended for use as an adjunct monitor of regional hemoglobin oxygen saturation of blood in the brain or in other tissue beneath the sensor.

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - 46615 - tissue saturation oximeter - the noninvasive invostm carescapetm* rso2 ? invostm parameter device when connected to the compatible host monitoring system is intended for use as an adjunct monitor of regional hemoglobin oxygen saturation of blood in the brain or in other tissue beneath the sensor.

Singapore - English - HSA (Health Sciences Authority)

draeger singapore pte ltd - cardiovascular - the monitors are capable of monitoring: heart rate, respiration rate, invasive pressure, non-invasive pressure, arrhythmia, temperature, cardiac output, arterial oxygen saturation, pulse rate, apnea, st segment analysis, 12-lead st segment analysis, tcpo2/tcpco2, eeg signals, fio2 and end tidal co2. scio gas module sampled breathing gases from adults and pediatrics. the gas module continuously measures the content of co2, n2o, o2 and one of the anesthetic agents, halothane, isoflurane, enflurane, sevoflurane and desflurane in any mixture and communicates real time and derived gas information to the infinity monitors. the devices are intended for use in the adult, pediatric and neonatal populations, with the exception of the parameter cardiac output, st segment analysis, and arrhythmia which are intended for use in the adult and pediatric populations only; and tcpo2 which is to be used in the neonatal population only when the patient is not under gas anesthesia.

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] acetaminophen and codeine phosphate tablets are contraindicated for: acetaminophen and codeine phosphate tablets are contraindicated in patients with: acetaminophen and codeine phosphate tablets contain codeine. codeine in combination with acetaminophen, a schedule iii controlled substance. acetaminophen and codeine phosphate tablets contain codeine, a substance with a high potential for abuse similar to other opioids, including fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxycodone, oxymorphone, and tapentadol. acetaminophen and c

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain,where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not provided adequate analgesia, or are not expected to provide adequate analgesia - have not been tolerated, or are not expected to be tolerated acetaminophen and codeine phosphate tablets are contraindicated in patients with: - patients with significant respiratory depression [see warnings].  - patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings].  - postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy [see warnings]

United States - English - NLM (National Library of Medicine)

mylan institutional inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not provided adequate analgesia, or are not expected to provide adequate analgesia, - have not been tolerated, or are not expected to be tolerated. acetaminophen and codeine phosphate tablets are contraindicated for: - all children younger than 12 years of age [see warnings ]. - post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy [see warnings ]. acetaminophen and codeine phosphate tablets are contraindicated in patients with: - significant respiratory depression [see warnings ].